Skip to main content
All lobbying filings

RELX INC.

RELX INC. filed a Q2 report for RELX INC on July 17, 2026.

Lobbying for RELX INC

All filings by RELX INC. · Everything RELX INC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Expenses
$750,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7

Issues related to support for consumer protection, fraud prevention and privacy. Issues related to comprehensive national privacy legislation.

Issues related to law enforcement investigative tools. Efforts to combat fraud and theft of pandemic relief benefits. Efforts to reduce unemployment insurance benefits fraud. Efforts to combat fraud and theft in small business loans. Efforts to prevent fraud in federal benefits. HR 7816, the Protect Liberty and End Warrantless Surveillance Act, provisions related to the Fourth Amendment is Not For Sale Act.

Issues related to copyright, including support for strong US intellectual property laws.

S 1082, Safeguarding Medicaid Act, all provisions. Promoted program integrity related to: Sec. 1940 of the Social Security Act, all provisions; and Sec. 1902(e) of the Social Security Act, all provisions related to income determined using modified adjusted gross income.

Issues relating to consumer directed health information exchange, interoperability, information blocking, patient access to health information, and provider directories. Issues relating to the impact of potential privacy legislation on Health Insurance Portability and Accountability Act (PL 104-191) and medical research. Issues related to the education and awareness of the benefits of using real world data in healthcare research and development. Raising awareness of the use of artificial intelligence in healthcare, health education and research and development. Issues related to promoting research integrity.

HR 8495, Financial Services and General Government Appropriations Act, provisions related to appropriate use of artificial intelligence in legal research. Issues relating to OMB draft rulemaking on federal financial assistance, grants policy, and Uniform Guidance requirements.

Issues related to global trade policy, including tariffs and their impact on goods entering the US.

 Bills named in this filing 2
  • H.R. 7816
    Protect Liberty and End Warrantless Surveillance Act of 2026
  • H.R. 8495
    Financial Services and General Government Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem